WO1998051667A1 - Indole derivatives and mono- and diazaindole derivatives - Google Patents
Indole derivatives and mono- and diazaindole derivatives Download PDFInfo
- Publication number
- WO1998051667A1 WO1998051667A1 PCT/JP1998/002139 JP9802139W WO9851667A1 WO 1998051667 A1 WO1998051667 A1 WO 1998051667A1 JP 9802139 W JP9802139 W JP 9802139W WO 9851667 A1 WO9851667 A1 WO 9851667A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- derivatives
- mono
- diazaindole
- indole
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Compounds represented by general formula (I), wherein A1 represents =N-, etc.; A2 represents =N- or =CH-; R1 represents hydrogen, etc.; R3 represents an alkyl, etc.; R4 represents an optionally substituted aryl, etc., hydrates thereof, and pharmaceutically acceptable salts of both. These compounds have COX-2 inhibitory activities and are useful as medicines such as an antiphlogistic.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU72379/98A AU7237998A (en) | 1997-05-16 | 1998-05-15 | Indole derivatives and mono- and diazaindole derivatives |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP12705997 | 1997-05-16 | ||
JP9/127059 | 1997-05-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1998051667A1 true WO1998051667A1 (en) | 1998-11-19 |
Family
ID=14950582
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP1998/002139 WO1998051667A1 (en) | 1997-05-16 | 1998-05-15 | Indole derivatives and mono- and diazaindole derivatives |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU7237998A (en) |
WO (1) | WO1998051667A1 (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001012187A2 (en) * | 1999-08-18 | 2001-02-22 | Astrazeneca Ab | Benzoic acid derivatives and their use as ppar receptor agonists |
WO2003029212A1 (en) * | 2001-09-27 | 2003-04-10 | F. Hoffmann-La Roche Ag | Indole derivatives as cox ii inhibitors |
US7442805B2 (en) | 2003-09-25 | 2008-10-28 | Wyeth | Substituted sulfonamide-indoles |
US7683091B2 (en) | 2005-08-17 | 2010-03-23 | Wyeth | Substituted indoles and methods of their use |
WO2011013624A1 (en) * | 2009-07-27 | 2011-02-03 | キッセイ薬品工業株式会社 | Indole derivative and pharmacologically acceptable salt thereof |
CN102498097A (en) * | 2009-07-27 | 2012-06-13 | 橘生药品工业株式会社 | Indole derivative and pharmacologically acceptable salt thereof |
JP2012167085A (en) * | 2011-01-25 | 2012-09-06 | Kissei Pharmaceutical Co Ltd | Medical application of indole derivative or pharmaceutically acceptable salt thereof |
WO2022195579A1 (en) | 2021-03-15 | 2022-09-22 | Saul Yedgar | Hyaluronic acid-conjugated dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (nsaids) for treating or alleviating inflammatory diseases |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995018799A1 (en) * | 1994-01-10 | 1995-07-13 | Merck Frosst Canada Inc. | Phenyl heterocycles as cox-2 inhibitors |
JPH08504408A (en) * | 1992-12-11 | 1996-05-14 | メルク フロスト カナダ インコーポレーテツド | 5-Methanesulfonamide-1-indanone as a cyclooxygenase-2 inhibitor |
JPH08157631A (en) * | 1994-10-05 | 1996-06-18 | Sekisui Chem Co Ltd | Crosslinked and foamed polyolefin and its production |
JPH08325249A (en) * | 1994-12-20 | 1996-12-10 | Japan Tobacco Inc | Oxazole derivative |
JPH0952882A (en) * | 1994-12-20 | 1997-02-25 | Japan Tobacco Inc | Oxazole heterocyclic aromatic compound |
JPH0977664A (en) * | 1995-09-13 | 1997-03-25 | Yakult Honsha Co Ltd | Specific inhibitor of cyclooxygenase-2 and anti-inflammatory agent |
-
1998
- 1998-05-15 AU AU72379/98A patent/AU7237998A/en not_active Abandoned
- 1998-05-15 WO PCT/JP1998/002139 patent/WO1998051667A1/en active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08504408A (en) * | 1992-12-11 | 1996-05-14 | メルク フロスト カナダ インコーポレーテツド | 5-Methanesulfonamide-1-indanone as a cyclooxygenase-2 inhibitor |
WO1995018799A1 (en) * | 1994-01-10 | 1995-07-13 | Merck Frosst Canada Inc. | Phenyl heterocycles as cox-2 inhibitors |
JPH08157631A (en) * | 1994-10-05 | 1996-06-18 | Sekisui Chem Co Ltd | Crosslinked and foamed polyolefin and its production |
JPH08325249A (en) * | 1994-12-20 | 1996-12-10 | Japan Tobacco Inc | Oxazole derivative |
JPH0952882A (en) * | 1994-12-20 | 1997-02-25 | Japan Tobacco Inc | Oxazole heterocyclic aromatic compound |
JPH0977664A (en) * | 1995-09-13 | 1997-03-25 | Yakult Honsha Co Ltd | Specific inhibitor of cyclooxygenase-2 and anti-inflammatory agent |
Non-Patent Citations (1)
Title |
---|
GLAMKOWSKI E. J., REITANO P. A.: "SYNTHESIS AND EVALUATION FOR DIURETIC ACTIVITY OF 1-SUBSTITUTED 6- CHLORO-5-SULFAMYLINDOLINES.", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, vol. 22., no. 01., 1 January 1979 (1979-01-01), US, pages 106 - 109., XP002912309, ISSN: 0022-2623, DOI: 10.1021/jm00187a023 * |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001012187A2 (en) * | 1999-08-18 | 2001-02-22 | Astrazeneca Ab | Benzoic acid derivatives and their use as ppar receptor agonists |
WO2001012187A3 (en) * | 1999-08-18 | 2001-06-07 | Astrazeneca Ab | Benzoic acid derivatives and their use as ppar receptor agonists |
WO2003029212A1 (en) * | 2001-09-27 | 2003-04-10 | F. Hoffmann-La Roche Ag | Indole derivatives as cox ii inhibitors |
US7442805B2 (en) | 2003-09-25 | 2008-10-28 | Wyeth | Substituted sulfonamide-indoles |
US7683091B2 (en) | 2005-08-17 | 2010-03-23 | Wyeth | Substituted indoles and methods of their use |
CN102498097A (en) * | 2009-07-27 | 2012-06-13 | 橘生药品工业株式会社 | Indole derivative and pharmacologically acceptable salt thereof |
WO2011013624A1 (en) * | 2009-07-27 | 2011-02-03 | キッセイ薬品工業株式会社 | Indole derivative and pharmacologically acceptable salt thereof |
CN102498096A (en) * | 2009-07-27 | 2012-06-13 | 橘生药品工业株式会社 | Indole derivative and pharmacologically acceptable salt thereof |
EP2474530A1 (en) * | 2009-07-27 | 2012-07-11 | Kissei Pharmaceutical Co., Ltd. | Indole derivative and pharmacologically acceptable salt thereof |
EP2474530A4 (en) * | 2009-07-27 | 2013-01-02 | Kissei Pharmaceutical | Indole derivative and pharmacologically acceptable salt thereof |
JPWO2011013624A1 (en) * | 2009-07-27 | 2013-01-07 | キッセイ薬品工業株式会社 | Indole derivatives or pharmacologically acceptable salts thereof |
US8680120B2 (en) | 2009-07-27 | 2014-03-25 | Kissei Pharmaceutical Co., Ltd. | Indole derivative or pharmaceutically acceptable salt thereof |
JP2012167085A (en) * | 2011-01-25 | 2012-09-06 | Kissei Pharmaceutical Co Ltd | Medical application of indole derivative or pharmaceutically acceptable salt thereof |
WO2022195579A1 (en) | 2021-03-15 | 2022-09-22 | Saul Yedgar | Hyaluronic acid-conjugated dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (nsaids) for treating or alleviating inflammatory diseases |
Also Published As
Publication number | Publication date |
---|---|
AU7237998A (en) | 1998-12-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3851199A (en) | Heterocyclic indole derivatives and mono- or diazaindole derivatives | |
EP1243583A4 (en) | Heterocyclic compounds having sulfonamide groups | |
PL327169A1 (en) | Naphtyl-substituted derivatives of benzimidazole as anticoagulants | |
CA2311742A1 (en) | 6-amino-9-benzyl-8-hydroxypurine derivatives | |
AU1282495A (en) | Anthranilic acid derivative | |
DK1104760T3 (en) | Sulfamoyl heteroarylpyrazole compounds as anti-inflammatory / analgesic agents | |
AU1025795A (en) | Prolineamide derivatives | |
EP1103552A4 (en) | Benzothiepin derivatives, process for the preparation of the same and uses thereof | |
AU4189796A (en) | Heteroaromatic oxazole compounds and use thereof | |
AU1200695A (en) | 4,5-diaryloxazole derivatives | |
CA2277947A1 (en) | Pyrrolidine derivatives having phospholipase a2 inhibitory activity | |
WO2001062705A8 (en) | Aminoalcohol derivatives | |
WO1999000373A8 (en) | Benzimidazole derivatives | |
WO1996004241A3 (en) | Benzoylguanidine derivatives as medicaments | |
EP1243268A4 (en) | Medicinal composition | |
WO2000005214A3 (en) | Isoquinolines as urokinase inhibitors | |
CA2120028A1 (en) | Indol Derivatives for the Treatment of Migrane | |
WO1998051667A1 (en) | Indole derivatives and mono- and diazaindole derivatives | |
NZ332481A (en) | 5-[2,4-diaminopyrimidinylmethyl]phenyl substituted propanone (or propenone) isoquinoline derivatives and medicaments | |
AU7257991A (en) | Indole derivatives | |
EP1043312A4 (en) | Heterocyclic compounds having nos inhibitory activities | |
EP1130015A4 (en) | Pyridazinone derivatives | |
WO1996005182A3 (en) | Saccharin derivatives | |
CA2300069A1 (en) | Naphthalimidobenzamide derivatives | |
EP1026162A4 (en) | Antirheumatic |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AU BA BB BG BR CA CN CU CZ EE GE GW HU ID IL IS KR LC LK LR LT LV MG MK MN MX NO NZ PL RO SG SI SK SL TR TT UA US UZ VN YU |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: CA |